Main > > >ENDOMETRIAL CARCINOMA. *

---

TREAT.: Lenvatinib+PembrolizuMAb.
Advanced Endometrial Carcinoma
Disease Progression>Prior Systemic The-rapy and are not candidates for curative Surgery or Radiation.
Not MicroSatellite Instability-High (MSI-H) or MisMatch Repair deficient (dMMR).
AU Approval Date : 2019. 09.17.
CA Approval Date : 2019. 09.17.
USA Approval Date: 2019. 09.17.
(*) Companies; TradeMark & Web-Site
Available on Request.
UpDate: 2019. 12.01.




>ENDOMETRIAL CARCINOMA. *'s products
This section has no products